The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Nanoparticle Technologies for Cancer Therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Self-citationRecent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“The first nanoscale drug delivery systems were lipid vesicles, which were first described in the 1960s and later became known as liposomes (Bangham et al. 1965).”
BackgroundCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 2×
“…in nanotechnology, with oncology already starting to reap the benefits of novel nanoscale technologies (Alexis et al. 2008b; Alexis et al. 2008c; Davis et al. 2008; Euliss et al. 2006; Farokhzad 2008; Farokhzad et al. 2006b; Farokhzad and Langer 2006; Freitas 2005; Jain 2008; Kawasaki and…”
BackgroundNanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Self-citationTargeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · cited 1×
“Knowledge of drug action pathways and cellular drug resistance mechanisms to specific drugs has allowed the development and evaluation of promising drug combinations (Kim et al. 2008; Szakacs et al. 2006).”
BackgroundLong-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Self-citationCedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Self-citationNanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Self-citationThe effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Self-citationPolymersomes: Tough Vesicles Made from Diblock Copolymers
Discher, B. M., Won, Y.-Y., Ege, D. S., Lee, J. C.-M., Bates, F. S., Discher, D. E., & Hammer, D. A. (1999) · Science · doi:10.1126/science.284.5417.1143 · Cited by 2,512
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Chithrani, B. D., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,286
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · cited 2×
“…et al. 2006b; Farokhzad and Langer 2006; Freitas 2005; Jain 2008; Kawasaki and Player 2005; Lanza et al. 2006; Levy-Nissenbaum et al. 2008; Moghimi et al. 2005; Peer et al. 2007; Pridgen et al. 2007; Riehemann et al. 2009; Rosen and Abribat 2005; Salvador-Morales et al. 2009a; Venugopal…”
BackgroundAmphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Self-citationPharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Targeted drug delivery via the folate receptor
Sudimack, J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,474
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
TGFβ: the molecular Jekyll and Hyde of cancer
Bierie, B., & Moses, H. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1926 · Cited by 1,267
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles
Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H.-S., Watson, N., Chen, S., Irvine, D. J., & Stellacci, F. (2008) · Nature Materials · doi:10.1038/nmat2202 · Cited by 1,266
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
Polymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
Self-citationDesai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Self-citationBagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C. (2007) · Nano Letters · doi:10.1021/nl071546n · Cited by 1,036
Self-citationEndocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Self-citationDavis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Self-citationMultifunctional magnetic nanoparticles for targeted imaging and therapy
MCCARTHY, J., & WEISSLEDER, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.014 · Cited by 892 · cited 2×
“…or radiation sensitizers (van Vlerken et al. 2008), combined therapeutic approaches such as photothermal and drug delivery (Park et al. 2008; Rapoport et al. 2007), and simultaneous delivery of therapeutic drugs and imaging agents (Gao et al. 2008; McCarthy and Weissleder 2008; Shin et al. 2009).”
BackgroundDirect Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials
Rolland, J. P., Maynor, B. W., Euliss, L. E., Exner, A. E., Denison, G. M., & DeSimone, J. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051977c · Cited by 852
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Sinha, R., Kim, G. J., Nie, S., & Shin, D. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0141 · Cited by 801
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Self-citationJohannsen, M., Gneveckow, U., Eckelt, L., Feussner, A., WaldÖFner, N., Scholz, R., Deger, S., Wust, P., Loening, S. A., & Jordan, A. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500158360 · Cited by 798
Protein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700465 · Cited by 777
Antibody targeted drugs as cancer therapeutics
Schrama, D., Reisfeld, R. A., & Becker, J. C. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1957 · Cited by 768
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Cheng, Y., Samia, A. C., Meyers, J. D., Panagopoulos, I., Fei, B., & Burda, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801631c · Cited by 733
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 715
Self-citationAlbumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J.-W., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.013 · Cited by 702
Self-citationVasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200700465 · Cited by 655
MINIATURE escherichia coli CELLS DEFICIENT IN DNA
Adler, H. I., Fisher, W. D., Cohen, A., & Hardigree, A. A. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.57.2.321 · Cited by 626
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform
Bagalkot, V., Farokhzad, O. C., Langer, R., & Jon, S. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602251 · Cited by 613
Self-citationMajoros, I. J., Myc, A., Thomas, T., Mehta, C. B., & Baker, J. R. (2006) · Biomacromolecules · doi:10.1021/bm0506142 · Cited by 596
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted Chemotherapy
Rapoport, N., Gao, Z., & Kennedy, A. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm043 · Cited by 562
Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S.-B., Rha, S. Y., Lee, M. Y., & Ro, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9591-y · Cited by 541 · cited 9×
“The maximum tolerated dose (MTD) of Genexol-PM is threefold higher than Taxol (60 mg kg 1 vs. 20 mg kg 1, respectively) and the median lethal tolerated dose (LD50) using Sprague–Dawley rats was reported to be ~20 times higher than Taxol.”
BackgroundInfluentialJohannsen, M., Gneveckow, U., Thiesen, B., Taymoorian, K., Cho, C. H., Waldöfner, N., Scholz, R., Jordan, A., Loening, S. A., & Wust, P. (2007) · European Urology · doi:10.1016/j.eururo.2006.11.023 · Cited by 532
Gary, D. J., Puri, N., & Won, Y.-Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.021 · Cited by 514
Shin, J., Anisur, R. M., Ko, M. K., Im, G. H., Lee, J. H., & Lee, I. S. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802323 · Cited by 475
Biodegradable polymers as non-viral carriers for plasmid DNA delivery
Luten, J., van Nostrum, C. F., De Smedt, S. C., & Hennink, W. E. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.028 · Cited by 471
Lipid-based systemic delivery of siRNA
Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 463
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
The adhesive strength of non-spherical particles mediated by specific interactions
Decuzzi, P., & Ferrari, M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.024 · Cited by 452
The Adaptive Immunologic Microenvironment in Colorectal Cancer: A Novel Perspective
Galon, J., Fridman, W.-H., & Pagès, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4806 · Cited by 447
Polymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Uchino, H., Matsumura, Y., Negishi, T., Koizumi, F., Hayashi, T., Honda, T., Nishiyama, N., Kataoka, K., Naito, S., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602772 · Cited by 430
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Juliano, R., Alam, M. R., Dixit, V., & Kang, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn342 · Cited by 429
Freitas, R. A. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2004.11.003 · Cited by 415
Poly(l-glutamic acid)–anticancer drug conjugates
Li, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00045-5 · Cited by 414
Poly(amidoamine) Dendrimer-Based Multifunctional Engineered Nanodevice for Cancer Therapy
Majoros, I. J., Thomas, T. P., Mehta, C. B., & Baker, J. R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0401863 · Cited by 395
Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A
Leserman, L. D., Barbet, J., Kourilsky, F., & Weinstein, J. N. (1980) · Nature · doi:10.1038/288602a0 · Cited by 391
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Imparting size, shape, and composition control of materials for nanomedicine
Euliss, L. E., DuPont, J. A., Gratton, S., & DeSimone, J. (2006) · Chemical Society Reviews · doi:10.1039/b600913c · Cited by 381
Lindman, S., Lynch, I., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Nano Letters · doi:10.1021/nl062743+ · Cited by 377
Cairns, R., Papandreou, I., & Denko, N. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0002 · Cited by 370
Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer
Kawasaki, E. S., & Player, A. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.03.002 · Cited by 368
Multifunctional Yolk−Shell Nanoparticles: A Potential MRI Contrast and Anticancer Agent
Gao, J., Liang, G., Cheung, J. S., Pan, Y., Kuang, Y., Zhao, F., Zhang, B., Zhang, X., Wu, E. X., & Xu, B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803920b · Cited by 366
Kim, D.-W., Kim, S.-Y., Kim, H.-K., Kim, S.-W., Shin, S. W., Kim, J. S., Park, K., Lee, M. Y., & Heo, D. S. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm374 · Cited by 356
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
van Vlerken, L. E., & Amiji, M. M. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.205 · Cited by 352
New frontiers in nanotechnology for cancer treatment
Alexis, F., Rhee, J.-W., Richie, J. P., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.017 · Cited by 347
Self-citationWong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Ahmed, F., Pakunlu, R. I., Srinivas, G., Brannan, A., Bates, F., Klein, M. L., Minko, T., & Discher, D. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050103u · Cited by 330
McCarthy, T. D., Karellas, P., Henderson, S. A., Giannis, M., O'Keefe, D. F., Heery, G., Paull, J. R. A., Matthews, B. R., & Holan, G. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050023q · Cited by 314
Kim, D., Lee, E. S., Oh, K. T., Gao, Z. G., & Bae, Y. H. (2008) · Small · doi:10.1002/smll.200701275 · Cited by 313
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas
Florence, A. T., & Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00184-3 · Cited by 308
MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K.-A., Brahmbhatt, V. N., Pattison, S. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.012 · Cited by 307
Gentile, F., Chiappini, C., Fine, D., Bhavane, R. C., Peluccio, M. S., Cheng, M. M.-C., Liu, X., Ferrari, M., & Decuzzi, P. (2008) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2008.03.021 · Cited by 304
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
The rise and rise of drug delivery
Rosen, H., & Abribat, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1721 · Cited by 296
Morgan, T. T., Muddana, H. S., Altinoǧlu, E. İ., Rouse, S. M., Tabaković, A., Tabouillot, T., Russin, T. J., Shanmugavelandy, S. S., Butler, P. J., Eklund, P. C., et al. (2008) · Nano Letters · doi:10.1021/nl8019888 · Cited by 295
Hamaguchi, T., Kato, K., Yasui, H., Morizane, C., Ikeda, M., Ueno, H., Muro, K., Yamada, Y., Okusaka, T., Shirao, K., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603855 · Cited by 290
Liggins, R. T., & Burt, H. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00016-9 · Cited by 286 · cited 3×
“2007), vesicle-based carriers such as liposomes (Kaneda 2000; Torchilin 2005), micelles (Fan 2008; Liggins and Burt 2002; Matsumura 2008), dendrimers (Florence and Hussain 2001; Lee et al.”
BackgroundNyman, D. W., Campbell, K. J., Hersh, E., Long, K., Richardson, K., Trieu, V., Desai, N., Hawkins, M. J., & Von Hoff, D. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6148 · Cited by 286
A Theoretical Model for the Margination of Particles within Blood Vessels
Decuzzi, P., Lee, S., Bhushan, B., & Ferrari, M. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8976-5 · Cited by 280
Poly (amino acid) micelle nanocarriers in preclinical and clinical studies
Matsumura, Y. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.010 · Cited by 275
Kester, M., Heakal, Y., Fox, T., Sharma, A., Robertson, G. P., Morgan, T. T., Altinoğlu, E. İ., Tabaković, A., Parette, M. R., Rouse, S. M., et al. (2008) · Nano Letters · doi:10.1021/nl802098g · Cited by 272
Nanotechnology and aptamers: applications in drug delivery
Levy-Nissenbaum, E., Radovic-Moreno, A. F., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.006 · Cited by 270
Self-citationBiofunctionalized targeted nanoparticles for therapeutic applications
Wang, A. Z., Gu, F., Zhang, L., Chan, J. M., Radovic-Moreno, A., Shaikh, M. R., & Farokhzad, O. C. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1063 · Cited by 270
Self-citationVisaria, R. K., Griffin, R. J., Williams, B. W., Ebbini, E. S., Paciotti, G. F., Song, C. W., & Bischof, J. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0381 · Cited by 268
Gratton, S. E. A., Pohlhaus, P. D., Lee, J., Guo, J., Cho, M. J., & DeSimone, J. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.027 · Cited by 266
Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Self-citationNanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Self-citationContext, tissue plasticity, and cancerAre tumor stem cells also regulated by the microenvironment?
BISSELL, M., & LABARGE, M. (2005) · Cancer Cell · doi:10.1016/s1535-6108(04)00375-7 · Cited by 255
Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 250
Self-citationBiodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
Self-citationNanomedicine: Application of Nanobiotechnology in Medical Practice
Jain, K. K. (2008) · Medical Principles and Practice · doi:10.1159/000112961 · Cited by 247
Nonviral methods for siRNA delivery
Gao, K., & Huang, L. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800134q · Cited by 244 · cited 1×
“Nucleic acid delivery technologies will not be included, but are extensively reported elsewhere (Chen and Huang 2008; Gao and Huang 2008; Gary et al. 2007; Juliano et al. 2008; Li and Huang 2008b; Luten et al. 2008; Tseng et al. 2009; Whitehead et al. 2009).”
BackgroundModulation of the Organ Microenvironment for Treatment of Cancer Metastasis
Fidler, I. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1588 · Cited by 240
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Heath, T. D., Fraley, R. T., & Papahdjopoulos, D. (1980) · Science · doi:10.1126/science.7423203 · Cited by 237
Cell-Permeable and Biocompatible Polymeric Nanoparticles for Apoptosis Imaging
Kim, K., Lee, M., Park, H., Kim, J.-H., Kim, S., Chung, H., Choi, K., Kim, I.-S., Seong, B. L., & Kwon, I. C. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057712f · Cited by 233
Feasibility Study of Particle-Assisted Laser Ablation of Brain Tumors in Orthotopic Canine Model
Schwartz, J. A., Shetty, A. M., Price, R. E., Stafford, R. J., Wang, J. C., Uthamanthil, R. K., Pham, K., McNichols, R. J., Coleman, C. L., & Payne, J. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2535 · Cited by 222
Ferrari, M. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.46 · Cited by 217
Paclitaxel poliglumex (XYOTAX™, CT-2103): A macromolecular taxane
Singer, J. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.033 · Cited by 213
Peracchia, M. T., Harnisch, S., Pinto-Alphandary, H., Gulik, A., Dedieu, J. C., Desmaële, D., d’Angelo, J., Müller, R. H., & Couvreur, P. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00021-6 · Cited by 208
Virosomes: evolution of the liposome as a targeted drug delivery system
Kaneda, Y. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00069-7 · Cited by 207
Self-Assembled Hybrid Nanoparticles for Cancer-Specific Multimodal Imaging
Kim, J. S., Rieter, W. J., Taylor, K. M. L., An, H., Lin, W., & Lin, W. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073062z · Cited by 204
Functionalized‐Quantum‐Dot–Liposome Hybrids as Multimodal Nanoparticles for Cancer
Al‐Jamal, W. T., Al‐Jamal, K. T., Bomans, P. H., Frederik, P. M., & Kostarelos, K. (2008) · Small · doi:10.1002/smll.200701043 · Cited by 199
Steric Stabilization of Lipid/Polymer Particle Assemblies by Poly(ethylene glycol)-Lipids
Thevenot, J., Troutier, A.-L., David, L., Delair, T., & Ladavière, C. (2007) · Biomacromolecules · doi:10.1021/bm700753q · Cited by 198
Couvreur, P., Kante, B., Roland, M., & Speiser, P. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600681215 · Cited by 186
Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
Zamboni, W. C. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0180 · Cited by 173
Singer, J. W., Baker, B., de Vries, P., Kumar, A., Shaffer, S., Vawter, E., Bolton, M., & Garzone, P. D. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-306-47932-x_6 · Cited by 168
Design maps for nanoparticles targeting the diseased microvasculature
Decuzzi, P., & Ferrari, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.025 · Cited by 168
HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy
Alexis, F., Basto, P., Levy‐Nissenbaum, E., Radovic‐Moreno, A. F., Zhang, L., Pridgen, E., Wang, A. Z., Marein, S. L., Westerhof, K., Molnar, L. K., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800122 · Cited by 164
Self-citationPark, H., Yang, J., Seo, S., Kim, K., Suh, J., Kim, D., Haam, S., & Yoo, K. (2008) · Small · doi:10.1002/smll.200700807 · Cited by 161
Andresen, T. L., Davidsen, J., Begtrup, M., Mouritsen, O. G., & Jørgensen, K. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031029r · Cited by 158
van Vlerken, L. E., Duan, Z., Little, S. R., Seiden, M. V., & Amiji, M. M. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800030k · Cited by 152
Advances and challenges of nanotechnology-based drug delivery systems
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.6.621 · Cited by 152
Imaging Pancreatic Cancer with a Peptide−Nanoparticle Conjugate Targeted to Normal Pancreas
Montet, X., Weissleder, R., & Josephson, L. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060035+ · Cited by 151
Shape-Specific, Monodisperse Nano-Molding of Protein Particles
Kelly, J. Y., & DeSimone, J. M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8014428 · Cited by 145
Multifunctional Cytotoxic Stealth Nanoparticles. A Model Approach with Potential for Cancer Therapy
Schneider, G. F., Šubr, V., Ulbrich, K., & Decher, G. (2009) · Nano Letters · doi:10.1021/nl802990w · Cited by 144
A novel pH-sensitive liposome formulation containing oleyl alcohol
Sudimack, J. J., Guo, W., Tjarks, W., & Lee, R. J. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00399-1 · Cited by 143
The margination propensity of spherical particles for vascular targeting in the microcirculation
Gentile, F., Curcio, A., Indolfi, C., Ferrari, M., & Decuzzi, P. (2008) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-6-9 · Cited by 132
Recent advances in liposome technologies and their applications for systemic gene delivery
Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00108-7 · Cited by 126
Wang, G., & Uludağ, H. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.499 · Cited by 126
Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer
Tejada‐Berges, T., Granai, C. O., Gordinier, M. E., & Gajewski, W. H. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.2.143 · Cited by 125
Campone, M., Rademaker-Lakhai, J. M., Bennouna, J., Howell, S. B., Nowotnik, D. P., Beijnen, J. H., & Schellens, J. H. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0397-0 · Cited by 125
Tsukioka, Y., Matsumura, Y., Hamaguchi, T., 小池浩代, Moriyasu, F., & Kakizoe, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01217.x · Cited by 123
Rice, J. R., Gerberich, J. L., Nowotnik, D. P., & Howell, S. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2169 · Cited by 117
Biophysical mechanisms of phospholipase A2 activation and their use in liposome‐based drug delivery
Jørgensen, K., Davidsen, J. R., & Mouritsen, O. G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03408-7 · Cited by 117
Guo, X. D., MacKay, J. A., & Szoka, F. C. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74986-8 · Cited by 116
Polymer-drug conjugates: current status and future trends
Greco, F., & Vicent, M. J. (2007) · Frontiers in bioscience · doi:10.2741/2882 · Cited by 113
Nanotechnology for Nanomedicine and Delivery of Drugs
Venugopal, J. R., Prabhakaran, M. P., Low, S., Choon, A. T., Zhang, Y., Deepika, G., & Ramakrishna, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740180 · Cited by 113
Boddy, A. V., Plummer, E. R., Todd, R., Sludden, J., Griffin, M., Robson, L., Cassidy, J., Bissett, D., Bernareggi, A., Verrill, M. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0803 · Cited by 108
Homsi, J., Simon, G. R., Garrett, C. R., Springett, G. M., Conti, R. C. D., Chiappori, A., Münster, P. N., Burton, M. K., Stromatt, S. C., Allievi, C., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2821 · Cited by 103
Gratton, S. E. A., Napier, M. E., Ropp, P. A., Tian, S., & DeSimone, J. M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9654-8 · Cited by 100
Intelligent therapeutics: biomimetic systems and nanotechnology in drug delivery
Peppas, N. A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.001 · Cited by 99
Siclari, V. A., Guise, T. A., & Chirgwin, J. M. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9023-1 · Cited by 95
Sood, P., Thurmond, K. B., Jacob, J. E., Waller, L. K., Silva, G. O., Stewart, D. R., & Nowotnik, D. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0600517 · Cited by 92
Multifunctional Polymeric Nanoparticles from Diverse Bioactive Agents
Bertin, P. A., Gibbs, J. M., Shen, C. K.-F., Thaxton, C. S., Russin, W. A., Mirkin, C. A., & Nguyen, S. T. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056378k · Cited by 90
Soepenberg, O., Dumez, H., Verweij, J., de Jong, F. A., de Jonge, M. J. A., Thomas, J., Eskens, F. A. L. M., van Schaik, R. H. N., Selleslach, J., ter Steeg, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1758 · Cited by 88
Jensen, S. S., Andresen, T. L., Davidsen, J. R., Høyrup, P., Shnyder, S. D., Bibby, M. C., Gill, J. H., & Jørgensen, K. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1451.3.11 · Cited by 86
Disposition of Drugs in Block Copolymer Micelle Delivery Systems: From Discovery to Recovery
Aliabadi, H. M., Shahin, M., Brocks, D. R., & Lavasanifar, A. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847100-00001 · Cited by 83
Pharmaceutical nanotechnology: polymeric vesicles for drug and gene delivery
Uchegbu, I. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.5.629 · Cited by 82
Nanotechnology for drug delivery: the perfect partnership
Farokhzad, O. C. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.9.927 · Cited by 79
Self-citationMoghimi, S. M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699130 · Cited by 76
Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors
Soepenberg, O., de Jonge, M. J. A., Sparreboom, A., de Bruin, P. C., Eskens, F. A. L. M., de Heus, G., Wanders, J., Cheverton, P., Ducharme, M. P., & Verweij, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.703.11.2 · Cited by 75
The scientific contributions of M. Judah Folkman to cancer research
Zetter, B. R. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2458 · Cited by 69
Vial, F., Rabhi, S., & Tribet, C. (2004) · Langmuir · doi:10.1021/la048039v · Cited by 63
Castor, T. P. (2005) · Current Drug Delivery · doi:10.2174/156720105774370195 · Cited by 63
Minko, T., Kopečková, P., Pozharov, V., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007500412442 · Cited by 62
Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy
Chen, Y., & Huang, L. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802568505 · Cited by 61
Nanocrystal-micelle: synthesis, self-assembly and application
Fan, H. (2007) · Chemical Communications · doi:10.1039/b711251n · Cited by 61
Flow chamber analysis of size effects in the adhesion of spherical particles.
Decuzzi, P., Gentile, F., Granaldi, A., Curcio, A., Causa, F., Indolfi, C., Netti, P. A., & Ferrari, M. (2007) · PubMed Central · Cited by 57
Posey, J. A., Saif, M. W., Carlisle, R. R., Goetz, A. D., Rizzo, J. D., Stevenson, S., Rudoltz, M. S., Kwiatek, J., Simmons, P., Rowinsky, E. K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0783 · Cited by 52
Polymer-protein and polymer-drug conjugates in cancer therapy.
Thanou, M., & Duncan, R. (2003) · PubMed · Cited by 50
Tribler, L., Jensen, L. T., Jørgensen, K., Brünner, N., Gelb, M. H., Nielsen, H. J., & Jensen, S. S. (2007) · PubMed · Cited by 44
Nanomedicine Opportunities in Cardiology
Lanza, G. M., Winter, P. M., Cyrus, T., Caruthers, S. D., Marsh, J. N., Hughes, M. S., & Wickline, S. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1380.034 · Cited by 36
Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li, S., & Huang, L. (2008) · PubMed · Cited by 33
Drug delivery systems in urology—getting “smarter”
Farokhzad, O. C., Dimitrakov, J. D., Karp, J. M., Khademhosseini, A., Freeman, M. R., & Langer, R. (2006) · Urology · doi:10.1016/j.urology.2006.03.069 · Cited by 33
Self-citationFreitas, R. A. (2005) · Disease-a-Month · doi:10.1016/j.disamonth.2005.08.003 · Cited by 30
Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
Najlah, M., & D’Emanuele, A. (2007) · PubMed · Cited by 29
Multifunctional nanoparticles for prostate cancer therapy
Salvador-Morales, C., Gao, W., Ghatalia, P., Murshed, F., Aizu, W., Langer, R., & Farokhzad, O. C. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.9.2.211 · Cited by 26
Self-citationDrug News and Trial Developments
(1995) · Aids Patient Care · doi:10.1089/apc.1995.9.306 · Cited by 17
Cited by
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Self-citationEffective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Cancer nanomedicine: from targeted delivery to combination therapy
Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693
Self-citationProtein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Lohcharoenkal, W., Wang, L., Chen, Y. C., & Rojanasakul, Y. (2014) · BioMed Research International · doi:10.1155/2014/180549 · Cited by 655
Kraft, J. C., Freeling, J. P., Wang, Z., & Ho, R. J. Y. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23773 · Cited by 606
Metadata
- Authors
- Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer Berlin Heidelberg
- Published
- 2009-11-19
- Issue
- 197
- Pages
- 55-86
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W92432531
- Cited by
- 364
- References
- 196
- FWCI
- 13.61
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.